Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.43 |
| ▸ | KDR | P35968 | 2/20 | 0.43 |
| ▸ | PTGIR | P43119 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP14 | P31944 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | CASP2 | P42575 | 1/20 | 0.41 |
| ▸ | CASP4 | P49662 | 1/20 | 0.41 |
| ▸ | CASP5 | P51878 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL114319 | 0.87 | CA1 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4422968 | 0.85 | CA1 (0.48) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL29089898 | 0.84 | CA1 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL22844960 | 0.80 | APP (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9479718 | 0.80 | SLC2A1 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9776389 | 0.79 | NQO1 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6152700 | 0.79 | CA4 (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5277509 | 0.78 | CA4 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9479727 | 0.78 | CA4 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL257718 | 0.78 | ACHE (0.68) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1234007-B1 | OLIGOMERIC METHINE DYES | CLARIANT FINANCE BVI LTD (VG) | 2004-02-18 | — | — | EP | disclosed |
| EP-1234007-A1 | OLIGOMERIC METHINE DYES | Clariant Finance (BVI) Limited (VG) | 2002-08-28 | — | — | EP | disclosed |
| US-20010012899-A1 | Oligomeric methine dyes | CLARIANT FINANCE ( BVI) LIMITED | 2001-08-09 | — | — | US | disclosed |
| WO-2001036543-A1 | OLIGOMERIC METHINE DYES | CLARIANT FINANCE (BVI) LIMITED (VG) | 2001-05-25 | — | — | WO | disclosed |
| US-4355823-A | Pressure-sensitive or heat-sensitive recording material | CIBA-GEIGY CORPORATION (US) | 1982-10-26 | — | — | US | disclosed |
| US-4256458-A | DIMERIC PYRIDINIUM DYES | BASF AKTIENGESELLSCHAFT (DE) | 1981-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010012899-A1 | Oligomeric methine dyes | INMT, DDT, DDC | CA12 3186/4885CA1 4077/4885CA2 3955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.